Smith+Nephew plc (LON:SN, NYSE:SNN) reports Q1 revenue of $1,386 million, up 2.9% underlying. Orthopaedics and Sports Medicine show strong growth. CEO confident in outlook.
Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024.
Smith+Nephew , the global medical technology company, announces the opening of Smith+Nephew Academy Singapore, a major medical education and digital innovation centre covering the Asia-Pacific. | November 10, 2022